BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8219187)

  • 1. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases.
    Mullen CA; Anderson KD; Blaese RM
    Blood; 1993 Nov; 82(10):2961-6. PubMed ID: 8219187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.
    Filipovich AH; Stone JV; Tomany SC; Ireland M; Kollman C; Pelz CJ; Casper JT; Cowan MJ; Edwards JR; Fasth A; Gale RP; Junker A; Kamani NR; Loechelt BJ; Pietryga DW; Ringdén O; Vowels M; Hegland J; Williams AV; Klein JP; Sobocinski KA; Rowlings PA; Horowitz MM
    Blood; 2001 Mar; 97(6):1598-603. PubMed ID: 11238097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged survival after splenectomy in Wiskott-Aldrich syndrome: a case report.
    Syrigos KN; Makrilia N; Neidhart J; Moutsos M; Tsimpoukis S; Kiagia M; Saif MW
    Ital J Pediatr; 2011 Sep; 37():42. PubMed ID: 21906397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome.
    Rumelhart SL; Trigg ME; Horowitz SD; Hong R
    Blood; 1990 Feb; 75(4):1031-5. PubMed ID: 2302455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant and persistent improvement of thrombocytopenia after splenectomy in an adult with the Wiskott-Aldrich Syndrome and intra-cerebral bleeding.
    Gaspoz JM; Waldvogel F; Cornu P; Gugler E; Dayer JM
    Am J Hematol; 1995 Mar; 48(3):182-5. PubMed ID: 7864026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation for the Wiskott-Aldrich syndrome. Long-term follow-up.
    Rimm IJ; Rappeport JM
    Transplantation; 1990 Oct; 50(4):617-20. PubMed ID: 2219285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome.
    Lum LG; Tubergen DG; Corash L; Blaese RM
    N Engl J Med; 1980 Apr; 302(16):892-6. PubMed ID: 6767187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Platelet function after allogeneic bone marrow transplantation in Wiskott-Aldrich syndrome].
    Megido M; Cesar JM; Maldonado MS; Otheo E; Muñoz A; Navarro JL
    Sangre (Barc); 1993 Jun; 38(3):233-4. PubMed ID: 8211550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early bone marrow transplantation in an infant with Wiskott-Aldrich syndrome.
    Beard LJ; Toogood IR; Pearson CC; Ferrante A
    Am J Pediatr Hematol Oncol; 1991; 13(3):310-4. PubMed ID: 1793157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center.
    Ozsahin H; Le Deist F; Benkerrou M; Cavazzana-Calvo M; Gomez L; Griscelli C; Blanche S; Fischer A
    J Pediatr; 1996 Aug; 129(2):238-44. PubMed ID: 8765621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome.
    Litzman J; Jones A; Hann I; Chapel H; Strobel S; Morgan G
    Arch Dis Child; 1996 Nov; 75(5):436-9. PubMed ID: 8957959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome.
    Brochstein JA; Gillio AP; Ruggiero M; Kernan NA; Emanuel D; Laver J; Small T; O'Reilly RJ
    J Pediatr; 1991 Dec; 119(6):907-12. PubMed ID: 1960605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Wiskott-Aldrich syndrome: the possibilities of diagnosis and treatment].
    Krisiukeniene A; Sitkauskiene B; Sakalauskas R
    Medicina (Kaunas); 2003; 39(3):211-6. PubMed ID: 12695631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unrelated donor BMT for Wiskott-Aldrich syndrome.
    Lenarsky C; Weinberg K; Kohn DB; Parkman R
    Bone Marrow Transplant; 1993 Aug; 12(2):145-7. PubMed ID: 8401361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of the Wiskott-Aldrich syndrome by a graft of allogeneic bone marrow].
    Fischer A; Durandy A; Bordigoni P; Virelizier JL; Vilmer E; Arnaud-Battandier F; Lagrue A; Olive D; Griscelli C
    Arch Fr Pediatr; 1984 Nov; 41(9):611-6. PubMed ID: 6391414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan.
    Kobayashi R; Ariga T; Nonoyama S; Kanegane H; Tsuchiya S; Morio T; Yabe H; Nagatoshi Y; Kawa K; Tabuchi K; Tsuchida M; Miyawaki T; Kato S
    Br J Haematol; 2006 Nov; 135(3):362-6. PubMed ID: 17032176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrelated donor marrow transplantation for congenital immunodeficiency and metabolic disease: an update of the experience of the Japan Marrow Donor Program.
    Sakata N; Kawa K; Kato K; Yabe H; Yabe M; Nagasawa M; Mugishima H; Kigasawa H; Tsuchida M; Akiyama Y; Morisima Y; Kodera Y; Kato S
    Int J Hematol; 2004 Aug; 80(2):174-82. PubMed ID: 15481448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding and splenectomy in Wiskott-Aldrich syndrome: A single-centre experience.
    Rivers E; Worth A; Thrasher AJ; Burns SO
    J Allergy Clin Immunol Pract; 2019 Mar; 7(3):1042-1044.e1. PubMed ID: 30048768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.